Writing in JAMA, the researchers led by Dr Lee Cohen, said the prevalence of depression in reproductiveagewomen, their level of anti-depressant use and the frequency of unplanned pregnancy, it was important to be able to tell patients about comparative risk of relapse linked to stopping or continuing with their medication.